10-(4'-fluorobenzyl)-2,10-dihydroimidazo[2,1-b]quinazolin-5(3H)-one hydrochloride
- $29.8 - $499.46
- Product name: 10-(4'-fluorobenzyl)-2,10-dihydroimidazo[2,1-b]quinazolin-5(3H)-one hydrochloride
- CAS: 58059-17-9
- MF: C17H15ClFN3O
- MW: 331.7719032
- EINECS:261-086-5
- MDL Number:MFCD00012648
- Synonyms:10-(4'-fluorobenzyl)-2,10-dihydroimidazo[2,1-b]quinazolin-5(3H)-one hydrochloride ;10-(4-fluorobenzyl)-2,10-dihydroimidazo[2,1-b]quinazolin-5;10-(4-FLUORO-BENZYL)-2,10-DIHYDRO-IMIDAZO(2,1-B)QUINAZOLIN-5(3H)-ONE, HCL
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 1MG
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0114804
- Product description10-(4-FLUOROBENZYL)-2,10-DIHYDROIMIDAZO(2,1-B)QUINAZOLIN-5(3H)-ONE HYDROCHLORIDE 95.00%
- Packaging5MG
- Price$499.46
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberR158380
- Product description10-(4-FLUORO-BENZYL)-2,10-DIHYDRO-IMIDAZO(2,1-B)QUINAZOLIN-5(3H)-ONE, HCL AldrichCPR
- Packaging1MG
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS463817
- Product description10-(4-FLUOROBENZYL)-2,10-DIHYDROIMIDAZO-(2,1-B)QUINAZOLIN-5(3H)-ONE HCL AldrichCPR
- Packaging1g
- Price$29.8
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0114804 | 10-(4-FLUOROBENZYL)-2,10-DIHYDROIMIDAZO(2,1-B)QUINAZOLIN-5(3H)-ONE HYDROCHLORIDE 95.00% | 5MG | $499.46 | 2021-12-16 | Buy |
Sigma-Aldrich | R158380 | 10-(4-FLUORO-BENZYL)-2,10-DIHYDRO-IMIDAZO(2,1-B)QUINAZOLIN-5(3H)-ONE, HCL AldrichCPR | 1MG | $29.8 | 2024-03-01 | Buy |
Sigma-Aldrich | S463817 | 10-(4-FLUOROBENZYL)-2,10-DIHYDROIMIDAZO-(2,1-B)QUINAZOLIN-5(3H)-ONE HCL AldrichCPR | 1g | $29.8 | 2024-03-01 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|